Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial

BACKGROUND: Hypofractionated radiotherapy is the current standard for adjuvant radiotherapy across many centres. Further hypofractionation may be possible but remains to be investigated in non-Caucasian populations with more advanced disease, with a higher proportion of patients requiring mastectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Sanjoy, Chakraborty, Santam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526182/
https://www.ncbi.nlm.nih.gov/pubmed/32998747
http://dx.doi.org/10.1186/s13063-020-04751-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526182/
https://www.ncbi.nlm.nih.gov/pubmed/32998747
http://dx.doi.org/10.1186/s13063-020-04751-y

Ejemplares similares